Best Business Newspaper

Influenza Vaccine Market Forecasts to reach more than US$ 1 Billion by 2022 across 5 major markets (5MM) – France, Germany, Italy, Spain and United Kingdom

Influenza Vaccine Market Size, Share, Trends and Forecasts to 2022
Influenza Vaccine Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against Influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries.

United Kingdom Influenza Vaccine market is the most attractive of those covered in the report. The United Kingdom market for influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Germany will be the second–largest market for influenza vaccine which is expected to grow at a CAGR of XX% by 2022. France is expected to be third largest influenza vaccine market being followed by Italy by the end of the forecasted period.

Get Complete Report Details at: http://www.orbisresearch.com/reports/index/influenza-vaccines-market-in-top-5-european-countries-to-2022-market-size-development-and-forecasts

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

Request a PDF Sample of this Report at: http://www.orbisresearch.com/contacts/request-sample/187220

The Influenza Vaccine Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into influenza vaccine sales forecast for the top five countries, comprising the UK, France, Italy, Spain and Germany until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials, pipeline and promising vaccines in influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market, such as Sanofi Pasteur, GSK, Sequirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. The report also entails major drivers and barriers of influenza vaccine market.

Five Major European Markets (5MM) covered in the Influenza Vaccine Market report are as follows:

1. United Kingdom

2. France

3. Italy

4. Spain

5. Germany

 

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose

2. Fluzone Quadrivalent

3. Intradermal (ID) Trivalent

4. Vaxigrip

5. Fluarix Quadrivalent

6. Flulaval Quadrivalent

7. Fluenz Tetra

8. FluMist Quadrivalent

9. Flublok

10. VN–100

11. M–001

12. VAX–2012Q

13. TAK – 850

14. Flucelvax Quadrivalent

15. Afluria Quadrivalent

16. Agrippal

17. Fluad

18. Fluvirin

19. Fluvax

For Any Enquiry, Drop a mail at enquiry@orbisresearch.com

Key Companies Covered in the Influenza Vaccine Market Report are as follows:

1. Sanofi Pasteur

2. GlaxoSmithKline(GSK)

3. Seqirus

4. AstraZenecca

5. Protein Sciences Corporation

6. Novavax

7. Daiichi–Sankyo

8. Mitsubishi Tanabe Pharma

9. BiondVax Pharmaceuticals Ltd

10. VaxInnate

 

Report Price: $1500 (Single User Licence)

Place a Purchase Order of this Report at: http://www.orbisresearch.com/contact/purchase/187220

 

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email: Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/influenza-vaccines-market-in-top-5-european-countries-to-2022-market-size-development-and-forecasts